153 related articles for article (PubMed ID: 15849356)
1. Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase.
Hang J; Zemskov EA; Lorand L; Belkin AM
J Biol Chem; 2005 Jun; 280(25):23675-83. PubMed ID: 15849356
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the interaction between transglutaminase 2 and fibronectin.
Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.
Lortat-Jacob H; Burhan I; Scarpellini A; Thomas A; Imberty A; Vivès RR; Johnson T; Gutierrez A; Verderio EA
J Biol Chem; 2012 May; 287(22):18005-17. PubMed ID: 22442151
[TBL] [Abstract][Full Text] [Related]
4. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition.
Akimov SS; Belkin AM
J Cell Sci; 2001 Aug; 114(Pt 16):2989-3000. PubMed ID: 11686302
[TBL] [Abstract][Full Text] [Related]
5. A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.
Chou CY; Streets AJ; Watson PF; Huang L; Verderio EA; Johnson TS
J Biol Chem; 2011 Aug; 286(31):27825-35. PubMed ID: 21652693
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.
Akimov SS; Krylov D; Fleischman LF; Belkin AM
J Cell Biol; 2000 Feb; 148(4):825-38. PubMed ID: 10684262
[TBL] [Abstract][Full Text] [Related]
7. The fibronectin-binding domain of transglutaminase.
Jeong JM; Murthy SN; Radek JT; Lorand L
J Biol Chem; 1995 Mar; 270(10):5654-8. PubMed ID: 7890687
[TBL] [Abstract][Full Text] [Related]
8. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
[TBL] [Abstract][Full Text] [Related]
9. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
[TBL] [Abstract][Full Text] [Related]
10. Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
Khanna M; Chelladurai B; Gavini A; Li L; Shao M; Courtney D; Turchi JJ; Matei D; Meroueh S
Mol Cancer Ther; 2011 Apr; 10(4):626-36. PubMed ID: 21330459
[TBL] [Abstract][Full Text] [Related]
11. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain.
Gaudry CA; Verderio E; Aeschlimann D; Cox A; Smith C; Griffin M
J Biol Chem; 1999 Oct; 274(43):30707-14. PubMed ID: 10521459
[TBL] [Abstract][Full Text] [Related]
12. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
[TBL] [Abstract][Full Text] [Related]
13. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
14. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
[TBL] [Abstract][Full Text] [Related]
15. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.
Király R; Csosz E; Kurtán T; Antus S; Szigeti K; Simon-Vecsei Z; Korponay-Szabó IR; Keresztessy Z; Fésüs L
FEBS J; 2009 Dec; 276(23):7083-96. PubMed ID: 19878304
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal peptide of the transglutaminase-activating metalloprotease inhibitor from Streptomyces mobaraensis accommodates both inhibition and glutamine cross-linking sites.
Juettner NE; Schmelz S; Anderl A; Colin F; Classen M; Pfeifer F; Scrima A; Fuchsbauer HL
FEBS J; 2020 Feb; 287(4):708-720. PubMed ID: 31420998
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primers.
Aeschlimann D; Koeller MK; Allen-Hoffmann BL; Mosher DF
J Biol Chem; 1998 Feb; 273(6):3452-60. PubMed ID: 9452468
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain.
Pickford AR; Potts JR; Bright JR; Phan I; Campbell ID
Structure; 1997 Mar; 5(3):359-70. PubMed ID: 9083105
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of fibrinogen and fibronectin binding from transglutaminase-mediated cross-linking at the hepatocyte surface.
Barsigian C; Fellin FM; Jain A; Martinez J
J Biol Chem; 1988 Oct; 263(28):14015-22. PubMed ID: 2902077
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical analyses of human plasma fibronectin-cytosolic transglutaminase interactions.
Achyuthan KE; Goodell RJ; Kennedye JR; Lee KN; Henley A; Stiefer JR; Birckbichler PJ
J Immunol Methods; 1995 Mar; 180(1):69-79. PubMed ID: 7534805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
